Russell Investments Group’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$613K Buy
21,908
+6,574
+43% +$185K ﹤0.01% 2685
2026
Q1
$437K Buy
15,334
+470
+3% +$16K ﹤0.01% 2552
2025
Q4
$588K Buy
14,864
+6,743
+83% +$247K ﹤0.01% 2430
2025
Q3
$286K Sell
8,121
-41,597
-84% -$1.43M ﹤0.01% 2680
2025
Q2
$1.63M Sell
49,718
-132,001
-73% -$4.29M ﹤0.01% 1826
2025
Q1
$5.86M Buy
181,719
+25,070
+16% +$931K 0.01% 1073
2024
Q4
$4.79M Buy
156,649
+12,212
+8% +$393K 0.01% 1191
2024
Q3
$4.05M Buy
144,437
+144,375
+232,863% +$3.56M 0.01% 1301
2024
Q2
$1.41K Sell
62
-535
-90% -$12.3K ﹤0.01% 3394
2024
Q1
$18.2K Buy
597
+530
+791% +$17.8K ﹤0.01% 2781
2023
Q4
$2.39K Buy
67
+59
+738% +$2.19K ﹤0.01% 2989
2023
Q3
$350 Buy
+8
New +$390 ﹤0.01% 3433
2021
Q3
– Sell
-2,952
Closed -$234K – 3042
2021
Q2
$234K Hold
2,952
– – ﹤0.01% 2861
2021
Q1
$193K Buy
+2,952
New +$182K ﹤0.01% 2843
2020
Q4
– Sell
-2,952
Closed -$117K – 3039
2020
Q3
$117K Hold
2,952
– – ﹤0.01% 2945
2020
Q2
$132K Hold
2,952
– – ﹤0.01% 2824
2020
Q1
$99K Hold
2,952
– – ﹤0.01% 2736
2019
Q4
$95K Hold
2,952
– – ﹤0.01% 2901
2019
Q3
$74K Buy
+2,952
New +$84.3K ﹤0.01% 2882

Other funds holding ATRC

Russell Investments Group's ATRC Position: Q2 2026 in Review

Russell Investments Group increased its AtriCure (ATRC) stake by 43% in Q2 2026, buying an estimated $185K and bringing the position to 21,908 shares worth $613K. The position accounts for ﹤0.01% of the portfolio, ranked #2685.

Russell Investments Group first reported a position in ATRC in Q3 2019 and has held it in 19 quarters since. The position peaked at $5.86M in Q1 2025. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Russell Investments Group held 21,908 shares of AtriCure worth $613K as of Q2 2026.
  • Russell Investments Group bought 6,574 AtriCure shares in Q2 2026, an estimated $185K.
  • AtriCure made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2685 holding.
  • Russell Investments Group first reported a position in AtriCure in Q3 2019 and has held it in 19 quarters since.
  • Russell Investments Group's AtriCure position peaked at $5.86M in Q1 2025.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.